Steve Jenkins
Steve Jenkins is an accomplished leader in the pharmaceutical industry. He’s the Executive Chairman of Beach Pharmaceuticals, a role he’s been flourishing in since January 2017. Jenkins brings a solid scientific foundation to his work, holding a Bachelor of Science degree in Chemistry from the University of Florida. His strong background and many years of experience in the industry give him unique insights and a deep understanding of the field, benefiting both Beach Pharmaceuticals and its readers.
Before his current position, Jenkins was the Chief Executive Officer of Beach Pharmaceuticals from June 2009 to December 2016. Over these years, he’s made significant contributions to strategic planning, product development, and crucial collaboration with the US Food and Drug Administration (FDA).
Beach Pharmaceuticals, the company behind Beelith, has greatly benefited from Jenkins’ leadership and expertise. His strategic involvement has been crucial in the development of products.
Jenkins is recognized by Wake Forest University for his strong contributions to the pharmaceutical industry. He’s featured on their “Leadership & Character Council” page, a group made up of influential leaders who guide and support the Program for Leadership and Character.
Jenkins, along with his wife, Carole, is passionate about supporting education and character formation initiatives. They have demonstrated this commitment by endowing a scholarship for the inaugural class of Leadership and Character Scholars in 2019 and serving as members of the Wake Forest Parents’ Council.
Carrying forward the legacy of his father, Richard Beach Jenkins, the founder of Beach Pharmaceuticals, Steve plays a significant role in the company’s operations. As an integral part of the Jenkins lineage, he continues to adapt and respond to the evolving demands of the healthcare sector, maintaining the family’s long-standing vision.